SPTX

18.1400.98%
DM

Denice M. Torres

Lead Independent Non-Employee Director

Ms. Denice M. Torres, M.B.A., J.D., is Lead Independent Non-Employee Director of Seaport Therapeutics, Inc. from 2026. Ms. Torres was Independent Non-Employee Director of Seaport Therapeutics, Inc. from May 2024 to 2026. She is Independent Director of Celldex Therapeutics, Inc. since June 05, 2025. Ms. Torres is Director of ByHeart, Inc. from December 2024. She served as an Independent Director at Karuna Therapeutics, Inc. since December 21, 2020 until March 18, 2024. She had been an Independent Director at Thirty Madison, Inc. since November 2022 and serves as an Independent Director at Glaukos Corporation since March 1, 2021. She has been a Director at National Resilience, Inc since 2020 and Wylei, Inc. since February 1, 2018. She had been Lead Independent Director and Independent Director of Surface Oncology, Inc. since July 6, 2021 until September 08, 2023 and served as its Independent Chairman since December 2021. Ms. Torres served as the President for J&J and an industry thought leader, with a strong background in digital marketing and executive management. She had been Independent Director at 2seventy bio, Inc. since October 15, 2021 until May 13, 2025 and served as a Lead Independent Director since April 1, 2024 until May 13, 2025. She joined the ranks of acclaimed Board Members including Meg Columbia-Walsh, John Martinson, Kevin Mably and Sheryl Goldstein. She is a senior executive with extensive healthcare and consumer experience. She served in roles of increasing authority at Johnson & Johnson from December 2004 to December 2017 and from 1990 to 2004. Ms. Torres held various senior commercial leadership roles at Eli Lilly and Company, including Executive Director of Global Neuroscience and Director of U. S. women’s health. At J&J, she served as Chief Strategy and Business Transformation Officer for the medical device sector from 2015 to 2017, Co-Chair of the North America Consumer Business, President of McNeil Consumer Healthcare from 2011 to 2015 and President of Janssen Pharmaceuticals, CNS from 2009 to 2011. From 2006 to 2009, she held various marketing positions at J&J. Ms. Torres was the sole recipient of the prestigious J&J HONOR award in 2016 for her work in diversity and inclusion and she was named the 2015 Woman of the Year by the Healthcare Businesswomen’s Association. Prior to J&J, she held senior commercialization roles with Lilly. Ms. Torres has extensive experience in corporate and portfolio strategy and has managed all major business functions. She led U. S. Women’s Health, Global Neuroscience and Growth Hormone. Ms. Torres is the Founder of The Mentoring Place, which she founded in 2017. She is also the Founder of The Ignited Company in November 2017 and serves as its Chief Executive Officer, a consulting firm specializing in the development of high-performing individuals and teams. She served as Director at bluebird bio, Inc. since August 10, 2020 until 2021. She has a strong background in marketing and is passionate about exceeding customer expectations. In 2015, she was selected Woman of the Year by Healthcare Business Women’s Association. She is a Member of the Michigan Bar Association. Ms. Torres has a BS in Psychology from Ball State University, JD -Law from Indiana University School of Law and MBA from the University of Michigan in 1990. She is M.A. Study of Happiness, Centenary University.

Positions